BARBARA STARR: Open Payments
NPI 1043287659 · MARLBOROUGH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 23 payments from 10 companies in 2025. Trend: 2023 $1,014 · 2024 $794 · 2025 $695
Food & beverage: $600Education: $95
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $172 |
| Janssen Biotech, Inc. | 4 | $150 |
| Lilly USA, LLC | 4 | $106 |
| ABBVIE INC. | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $33 |
| Botanix SB Inc | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $17 |
Products named: OTEZLA, TREMFYA, TALTZ, SKYRIZI, COSENTYX, ILUMYA, Sotyktu, SOFDRA.
Industry payments across MA — which companies pay providers there.
